FR0000131104 - Common Stock

Taking everything into account, **BNP** scores **3** out of 10 in our fundamental rating. **BNP** was compared to 92 industry peers in the **Banks** industry. **BNP** may be in some trouble as it scores bad on both profitability and health. **BNP** has a decent growth rate and is not valued too expensively.

Each year in the past 5 years **BNP** has been profitable.

In multiple years **BNP** reported negative operating cash flow during the last 5 years.

With a decent **Return On Equity** value of **12.65%**, **BNP** is doing good in the industry, outperforming **76.14%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.57% | ||

ROE | 12.65% | ||

ROIC | N/A |

ROA(3y)0.37%

ROA(5y)0.35%

ROE(3y)7.98%

ROE(5y)7.4%

ROIC(3y)N/A

ROIC(5y)N/A

Looking at the **Profit Margin**, with a value of **15.91%**, **BNP** is doing worse than **70.45%** of the companies in the same industry.

In the last couple of years the **Profit Margin** of **BNP** has grown nicely.

The **Operating Margin** and **Gross Margin** are not available for **BNP** so they could not be analyzed.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | 15.91% | ||

GM | N/A |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y8.95%

PM growth 5Y3.87%

GM growth 3YN/A

GM growth 5YN/A

Compared to 1 year ago, **BNP** has less shares outstanding

Compared to 1 year ago, **BNP** has a worse debt to assets ratio.

A Debt/Equity ratio of **2.05** is on the high side and indicates that **BNP** has dependencies on debt financing.

With a **Debt to Equity ratio** value of **2.05**, **BNP** perfoms like the industry average, outperforming **50.00%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.05 | ||

Debt/FCF | N/A | ||

Altman-Z | N/A |

ROIC/WACCN/A

WACC4.86%

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | N/A | ||

Quick Ratio | N/A |

The **Earnings Per Share** has grown by an nice **19.93%** over the past year.

Looking at the last year, **BNP** shows a small growth in **Revenue**. The Revenue has grown by **6.08%** in the last year.

Measured over the past years, **BNP** shows a small growth in **Revenue**. The Revenue has been growing by **3.54%** on average per year.

EPS 1Y (TTM)19.93%

EPS 3Y20.12%

EPS 5Y9.45%

EPS Q2Q%28.51%

Revenue 1Y (TTM)6.08%

Revenue growth 3Y6.32%

Revenue growth 5Y3.54%

Sales Q2Q%7.98%

The **Revenue** is expected to grow by **4.39%** on average over the next years.

EPS Next Y2.25%

EPS Next 2Y4.75%

EPS Next 3Y5.89%

EPS Next 5Y2.3%

Revenue Next Year3.82%

Revenue Next 2Y4.13%

Revenue Next 3Y4.14%

Revenue Next 5Y4.39%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

A **Price/Earnings** ratio of **5.83** indicates a rather cheap valuation of **BNP**.

Based on the **Price/Earnings** ratio, **BNP** is valued a bit cheaper than the industry average as 76.14% of the companies are valued more expensively.

Compared to an average S&P500 **Price/Earnings** ratio of **28.79**, **BNP** is valued rather cheaply.

Based on the **Price/Forward Earnings** ratio of **5.77**, the valuation of **BNP** can be described as very cheap.

Based on the **Price/Forward Earnings** ratio, **BNP** is valued cheaper than 87.50% of the companies in the same industry.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **20.38**, **BNP** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 5.83 | ||

Fwd PE | 5.77 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | N/A |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates **BNP** does not grow enough to justify the current Price/Earnings ratio.

PEG (NY)2.59

PEG (5Y)0.62

EPS Next 2Y4.75%

EPS Next 3Y5.89%

With a **Yearly Dividend Yield** of **7.74%**, **BNP** is a good candidate for dividend investing.

Compared to an average industry **Dividend Yield** of **5.89**, **BNP** pays a bit more dividend than its industry peers.

Compared to an average S&P500 **Dividend Yield** of **2.32**, **BNP** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 7.74% |

Dividend Growth(5Y)N/A

Div Incr Years2

Div Non Decr Years2

DP0%

EPS Next 2Y4.75%

EPS Next 3Y5.89%

**BNP PARIBAS**

EPA:BNP (8/9/2024, 7:00:00 PM)

**59.25**

**-0.17 (-0.29%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap66.95B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 7.74% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 5.83 | ||

Fwd PE | 5.77 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)2.59

PEG (5Y)0.62

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.57% | ||

ROE | 12.65% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | 15.91% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.04

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.05 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | N/A | ||

Quick Ratio | N/A | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)19.93%

EPS 3Y20.12%

EPS 5Y

EPS Q2Q%

EPS Next Y2.25%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)6.08%

Revenue growth 3Y6.32%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y